BTS 2014 Report: A case I wish I never did
Maria Dalby reporting on the presentation by Dorry Segev, Johns Hopkins University, Baltimore, USA – Every transplant surgeon has had his/her share of cases that turned out less… read more.
Maria Dalby reporting on the presentation by Dorry Segev, Johns Hopkins University, Baltimore, USA – Every transplant surgeon has had his/her share of cases that turned out less… read more.
From the annual meeting of the British Transplantation Society in Glasgow by Marc J. Clancy. Since its establishment within the mainstream of clinical care, the technology of organ… read more.
Researchers have pinpointed why normal aging is accompanied by a diminished ability to regain strength and mobility after muscle injury: Over time, stem cells within muscle tissues dedicated… read more.
Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated. Investigators have reported more encouraging news about one of the most exciting methods… read more.
by Bruce Sylvester – Researchers have developed a new method to predicting which patients with heart failure will do well with treatment and which patients will not.
First therapy to target damage after heart attack could transform field. After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells… read more.
Researchers found a novel approach to predict outcomes in heart failure patients by imaging impaired energy metabolism in a diseased heart. Researchers have identified a new method to… read more.
by Bruce Sylvester – While early stem cell transplantation in patients with aggressive non-Hodgkin’s lymphoma does not improve overall survival in intermediate/high-risk patients, early transplantation appears to be… read more.
by Bruce Sylvester – While early stem cell transplantation in patients with aggressive non-Hodgkin’s lymphoma does not improve overall survival in intermediate/high-risk patients, early transplantation appears to be… read more.
by Bruce Sylvester – Diflunisal, a generic anti-inflammatory drug, appears to reduce neurological decline and preserve quality-of-life in patients with familial transthyretin amyloidosis (ATTR).
Bernhard Banas, Regensburg, Germany – Prolonged-release tacrolimus administered once-daily provides high rates of graft survival and reduction in biopsy-confirmed acute rejection (BCAR), with a manageable tolerability profile, in… read more.
by Pavel Trunečka, Prague, Czech Republic – Starting on a low dose of prolonged-release, once-daily tacrolimus after liver transplantation achieved better renal function and a significantly lower risk… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.